Elan Pharmaceutical Technologies
Records under this name other than patents Elan Pharmaceutical Technologies holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Elan Pharmaceutical Technologies
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,171,965 | Breath Actuated Dry Powder Inhaler and Tape Dose Strip Formerly held Lapsed on the fee record Ended Feb 6, 2019 · Medium confidence | Lapsed on the fee record | Ended Feb 6, 2019 | Medium confidence |
| US 6,339,069 | Peptide-lipid conjugates, liposomes and lipsomal drug delivery Term ended Ended no later than Oct 15, 2017 · USPTO record | Term ended | Ended no later than Oct 15, 2017 | USPTO record |
| US 6,941,947 | Unit dose dry powder inhaler Formerly held Lapsed on the fee record Ended Sep 13, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 13, 2017 | USPTO record |